sorafenib
(sorafenib)Yabao Pharmaceutical Co., Ltd. Beijing
Usage: Sorafenib tablets are indicated for patients with unresectable hepatocellular carcinoma (HCC) and those with locally recurrent or metastatic, progressive differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.